Add time:08/18/2019         Source:sciencedirect.com

Human rhinoviruses (HRVs) are the most common cause of viral respiratory infections and their complications. So far, no anti-viral agent has been approved for prevention or treatment of HRV infections. Pursuing our researches on small molecules with anti-rhinovirus activity, in this paper we describe the synthesis and in vitro anti-HRV 1B and 14 properties of new [2-(2H-chromen-3-yl)vinyl]pyridines and 3-[2-(pyridinyl)vinyl]-4H-chromen-4-ones. Generally, the synthesized compounds interfered with the replication of both serotypes at the micromolar or submicromolar concentrations. Preliminary results on their mechanism of action, performed on selected (E)-2-[2-(2H-chromen-3-yl)vinyl]pyridine, indicate an interference with the early step(s) of HRV 1B and 14 replication, probably at the uncoating level.

We also recommend Trading Suppliers and Manufacturers of (R)-N-Methyl-2-(3-pyridinyl)-3,4,5,6-tetrahydro-2H-thiopyran-2-carbothioamide 1-oxide (cas 132562-26-6). Pls Click Website Link as below: cas 132562-26-6 suppliers